معرفی
Sarah Pyne serves as a Senior Research Associate at the University of East Anglia's Norwich Medical School, with dual affiliations in Public Health and Health Economics. Her work focuses on economic evaluations of clinical interventions across multiple medical specialties.
Her research spans health economics and cost-effectiveness analysis in diverse domains including stroke rehabilitation, dermatological treatments, and neurosurgical procedures. Key thematic areas include vocational rehabilitation for stroke survivors, comparative effectiveness of acne treatments in women, and surgical interventions for subdural hematomas. Her methodological expertise centers on health technology assessment and economic modeling within randomized controlled trials.
Recent publication trends reveal a strong emphasis on economic evaluations integrated with major clinical trials. Her work consistently addresses cost-effectiveness questions in dermatology (particularly acne treatments), neurosurgery (subdural hematoma management), and stroke rehabilitation. These studies typically employ sophisticated economic modeling techniques applied to large-scale multicenter trials funded by major health research bodies.
Pyne actively collaborates on significant research projects funded by the National Institute for Health and Care Research (NIHR) and industry partners like Pfizer. Her grant portfolio includes leadership roles in the RETAKE stroke rehabilitation study, FUSION 4 DCM cervical myelopathy research, and BEACON eczema treatment trial. These projects involve complex cost-consequence analyses integrated with clinical outcomes assessment.
She contributes to the RETAKE research group and collaborates extensively with clinical teams across neurosurgery, dermatology, and rehabilitation medicine. Her work bridges health economics with clinical practice through partnerships with major UK healthcare institutions and international research networks.
